Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism ABHD6 inhibitors(abhydrolase domain containing 6, acylglycerol lipase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | JP | 11 Jan 2024 | |
Inflammation | Preclinical | JP | 11 Jan 2024 | |
Metabolic Diseases | Preclinical | JP | 11 Jan 2024 | |
Neoplasms | Preclinical | JP | 11 Jan 2024 | |
Pain | Preclinical | JP | 11 Jan 2024 |